National Investment Services Inc. WI reduced its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 6.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,453 shares of the medical research company’s stock after selling 1,075 shares during the quarter. Thermo Fisher Scientific comprises 2.8% of National Investment Services Inc. WI’s portfolio, making the stock its 7th largest holding. National Investment Services Inc. WI’s holdings in Thermo Fisher Scientific were worth $2,696,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Proficio Capital Partners LLC raised its stake in shares of Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares in the last quarter. Cribstone Capital Management LLC lifted its holdings in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after buying an additional 50 shares during the period. Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $113,000. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $108,000. Finally, CWM LLC lifted its holdings in shares of Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 103 shares during the period. 83.36% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Thermo Fisher Scientific Inc (TMO) Holdings Cut by National Investment Services Inc. WI” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/04/thermo-fisher-scientific-inc-tmo-holdings-cut-by-national-investment-services-inc-wi.html.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 190.33 on Wednesday. The stock has a market cap of $74.25 billion, a P/E ratio of 33.16 and a beta of 1.05. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $194.30. The company has a 50 day moving average of $185.02 and a 200 day moving average of $173.34.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.03 earnings per share. Equities research analysts expect that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.45%.

In other news, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the sale, the director now directly owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,738 shares of company stock worth $9,302,112. Company insiders own 0.49% of the company’s stock.

A number of research analysts recently issued reports on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a report on Thursday, September 7th. Morgan Stanley reissued an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Cowen and Company reissued a “buy” rating and issued a $200.00 price target on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Bank of America Corporation restated a “buy” rating and set a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. One research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $202.21.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.